Alzheimer’s disease (AD) is pathologically characterized by extracellular plaques composed of amyloid beta (Aβ) proteins that are produced by amyloidogenic cleavage of Aβ-precursor protein (AβPP), a process controlled by the rate-limiting beta-site AβPP cleaving enzyme (BACE-1). The gene discussed is APP; the disease is Alzheimer disease.